To view this email as a web page, click here

Today's Rundown

Featured Story

Vir, GSK unveil final data for COVID-19 antibody en route to 2021 filing

With final phase 3 data in hand, Vir Biotechnology and GlaxoSmithKline are seeking full approval for their COVID-19 antibody by the end of the year. The study found that the treatment, sotrovimab, slashed hospitalizations and deaths by 79% in adults with mild to moderate COVID-19 who were at high risk of their disease becoming severe.

read more

Top Stories

AstraZeneca, Novavax partner SK Bioscience eyes $132M vaccine production boost—and looks to add mRNA to the menu

COVID-19 production pacts have elevated the profile of numerous biopharmas during the pandemic, and that's certainly true for AstraZeneca and Novavax's partner SK Bioscience. The company is now channeling its recent momentum into a sizable manufacturing expansion at home.

read more

With ACA safe, Biden administration putting focus on health disparities

With the Affordable Care Act legally safe—for now—the Biden administration is turning its eyes to addressing health inequity.

read more

Not done yet: Roche nets new FDA COVID-19 authorization for point-of-care PCR screening test

Though the demand for COVID-19 testing is beginning to wind down, Roche is aiming to make the most of what’s left, with a new molecular test designed to help healthcare workers track the pandemic over the long haul.

read more

COVID-19 tracker: MSF calls on BioNTech to share vaccine know-how; U.S. won't immediately donate AZ doses

International humanitarian group MSF called on BioNTech to share its vaccine technology with developing countries. AstraZeneca vaccine doses will not be included in the first donations from the U.S. to other countries. And more headlines.

read more

UPDATED Coronavirus tracker: Study ties birthday gatherings to increased COVID spread

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

read more